Client News

American Rebel (NASDAQ: AREB) Reports Financial Results for the Year Ended December 31, 2023

Nashville, TN, April 16, 2024 (GLOBE NEWSWIRE) — American Rebel Holdings, Inc. (NASDAQ: AREB) (“American Rebel” or the “Company”), a designer, manufacturer, and marketer of branded safes, personal security and self-defense products and apparel, and American Rebel Beer (americanrebelbeer.com), announced its financial results for the year ended December 31, 2023. Investors are encouraged to read […]

Laser Photonics (NASDAQ: LASE) To Attend NCMS CTMA Partners Meeting With Its Selection of Laser Solutions

ORLANDO, Fla., April 16, 2024–(BUSINESS WIRE)–Laser Photonics Corporation (LPC) (NASDAQ: LASE), a leading global developer of industrial laser systems for cleaning and other material processing applications, announced today that it is attending this year’s NCMS Commercial Technologies for Maintenance Activities (CTMA) Partners Meeting. Set to take place from May 7 to May 9 in Providence, Rhode Island, the […]

Mawson Infrastructure Group Inc. (NASDAQ: MIGI) Announces New Board Chair

New Board Chair Appointment Highlights Continued Company Transformation and Enhances Focus on U.S. Operations and Growth Opportunities MIDLAND, Pa., April 15, 2024 (GLOBE NEWSWIRE) — Mawson Infrastructure Group Inc. (NASDAQ: MIGI) (“Mawson” or the “Company”), a digital infrastructure provider, announced that the Board of Directors of the Company has appointed Ryan Costello as the Chair […]

Longeveron’s (NASDAQ: LGVN) CLEAR MIND Randomized Phase 2a Clinical Trial Evaluating Lomecel-B™ in Mild Alzheimer’s Disease Accepted for Featured Research Session Oral Presentation at the 2024 Alzheimer’s Association International Conference (AAIC)

MIAMI, April 15, 2024 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company developing regenerative medicines, today announced that it has been accepted for a Featured Research Oral Presentation to present the Company’s CLEAR MIND Phase 2a study results. CLEAR-MIND is a Phase 2a randomized clinical trial evaluating Lomecel-BTM in mild Alzheimer’s Disease. In addition to the clinical […]

Laser Photonics (NASDAQ:LASE) Provides Shareholder Letter and Announces Fourth Quarter and Year-End 2023 Results

Fourth quarter revenue grew by 673% Fourth quarter operating and net losses improved by 36% and 86%, respectively ORLANDO, FL / ACCESSWIRE / April 15, 2024 / Laser Photonics Corporation (LPC) (NASDAQ:LASE), a leading global industrial developer of CleanTech Laser Systems for laser cleaning and other applications, today announced financial results for its fourth quarter and year ended […]

Pursuant to NYSE Regulations, Splash Beverage Group (NYSE American: SBEV) Acknowledges the Going Concern Language in Its 10K and Reaffirms Its Commitment to Success

FORT LAUDERDALE, FL, April 12, 2024 (GLOBE NEWSWIRE) — via NewMediaWire — Splash Beverage Group, Inc. (NYSE American: SBEV) (“Splash” or the “Company”), a portfolio company of leading beverage brands, issued a statement today reaffirming its commitment to sustainable growth and long-term success despite a going concern opinion. This advisement does not represent any change or amendment to […]

Digital Brands Group (NASDAQ: DBGI) to Report Fourth Quarter and Fiscal Year 2023 Financial Results on Monday, April 15, 2024

AUSTIN, April 12, 2024 /PRNewswire/ — Digital Brands Group, Inc. (“DBG”)  (NASDAQ: DBGI), a curated collection of luxury lifestyle, digital-first brands,  will report financial results for the fourth quarter ended December 31, 2023 on Monday, April 15, 2023 at 4:30 p.m. ET. Management will host a conference call on Monday, April 15 at 5:00 p.m. ET to discuss the results. The live conference call can be accessed by […]

Longeveron (NASDAQ: LGVN) Announces Closing of $5.2 Million Public Offering

MIAMI, April 11, 2024 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or the “Company”), a clinical stage biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions such as hypoplastic left heart syndrome (HLHS), Alzheimer’s disease and Aging-related Frailty, today announced the closing of its previously announced public offering of up to 2,234,043 shares […]

SciSparc (Nasdaq: SPRC) to Acquire AutoMax

TEL AVIV, Israel, April 11, 2024 (GLOBE NEWSWIRE) — SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders and rare diseases of the central nervous system, announced today that it signed a merger agreement (the “Agreement”) with AutoMax Motors Ltd. (“AutoMax”), a leading […]

Start Expanding
Your Shareholder Base

Let us help you connect with investors
committed to your success.